Research in mice pinpoints immune mechanism behind tissue damage and complications of chlamydia infection, the most common sexually transmitted disease in the United States.
Separate immune mechanisms drive bacterial clearance versus...
13-Feb-2018 12:35 PM EST Add to Favorites
Antibodies made by camels, llamas and alpacas allow scientists to study the structure and function of proteins in disease and health.
While valuable, the approach is time-consuming, costly and often unsuccessful.
Overcoming this barrier,...
8-Feb-2018 11:15 AM EST Add to Favorites
Is it nature or nurture that ultimately shapes an organism? A new study reveals a dramatic landscape of gene expression changes across all cell types in the mouse visual cortex after a sensory experience, many linked to neural connectivity and the...
8-Feb-2018 10:05 AM EST Add to Favorites
Harvard Medical School scientists have identified the molecular machinery responsible for secretion of the neurotransmitter dopamine, opening door for new strategies to precision target dopamine release.
30-Jan-2018 3:05 PM EST Add to Favorites
Drug Discount Program Aimed at Improving Care for Low-Income Patients Generated Gains for Hospitals Without Clear Benefits for the Needy
A 25-year-old drug discount program aimed at boosting resources for hospitals treating low-income patients did not deliver on its promise to enhance care for the needy, according to research from Harvard Medical School and the NYU School of Medicine.
24-Jan-2018 6:05 PM EST Add to Favorites
Researchers reveal in detail how fertilization triggers destruction of a small number of proteins, which releases the “brakes” on an egg’s cell cycle. Simultaneously, vast quantities of proteins are rapidly secreted from the egg to help...
21-Dec-2017 12:05 PM EST Add to Favorites
Harvard Medical School will offer online education to doctors-in-the-making and practicing clinicians affiliated with a pediatric cancer hospital in Egypt, the 57357 Children’s Cancer Hospital in Cairo.
21-Dec-2017 8:05 AM EST Add to Favorites
Benefits of many cancer drug combinations are not due to drug synergy, but to “bet hedging.” Combinations give each patient multiple chances of responding to at least one drug, increasing survival within patient populations. Findings suggest new...
12-Dec-2017 1:05 PM EST Add to Favorites